The leading position of BIO's Desci track is not a problem. It's normal for first-level private equity and second-level public offerings to sell part of the profits shortly after going live. The concept is fine; we can look for opportunities to buy some after it stabilizes. It can be considered around 0.5, which has a good cost-performance ratio.

#BIO开盘 #加密市场反弹